Search results
Z11.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Encntr screen for infections w sexl mode of transmiss. The 2024 edition of ICD-10-CM Z11.3 became effective on October 1, 2023.
- 2024 ICD-10-CM Diagnosis Code Z11 - The Web's Free 2023 ICD-10-CM/PCS ...
Note. Z codes represent reasons for encounters. A...
- 2024 ICD-10-CM Diagnosis Code Z13.29: Encounter for screening ...
Z13.29 is a billable/specific ICD-10-CM code that can be...
- 2024 ICD-10-CM Diagnosis Code Z11 - The Web's Free 2023 ICD-10-CM/PCS ...
People also ask
What are STI screening and treatment guidelines?
Should Chlamydia be screened for cisgender women?
When should a woman be screened for HIV?
How are Chlamydia recommendations coded?
Z13.29 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Encounter for screening for oth suspected endocrine disorder. The 2024 edition of ICD-10-CM Z13.29 became effective on October 1, 2023.
Z11.3 is a billable diagnosis code used to specify a medical diagnosis of encounter for screening for infections with a predominantly sexual mode of transmission. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.
Z11.51 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2024 edition of ICD-10-CM Z11.51 became effective on October 1, 2023. This is the American ICD-10-CM version of Z11.51 - other international versions of ICD-10 Z11.51 may differ.
Z13.29 is a billable diagnosis code used to specify a medical diagnosis of encounter for screening for other suspected endocrine disorder. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA ...
Consider screening for women receiving care in high-prevalence settings (e.g., STI clinics and correctional facilities) and for asymptomatic women at increased risk for infection (e.g., women with multiple sex partners, transactional sex, drug misuse, or a history of STI or incarceration) 2
Mar 24, 2021 · AAFP recommends screening for men who have sex with men (MSM) if at risk (rather than all sexually active MSM), while ACOG recommends routinely screening all pregnant women (rather than just those under 25 and those >25 with risk factors). TABLE B-1 Screening and Treatment Recommendations, Chlamydia.
